In today’s Pharma Pulse, Johnson & Johnson commits over $1 billion to a new biomanufacturing site in Pennsylvania, while Hims ...

Patients want pills. We see this in the GLP-1 space. Everything should actually be flowing money towards pills, because payers are also quicker to reward pills. Yet the money is going exactly in the ...

A policy change allowing approval of some new drugs based on one adequate and well-controlled study could accelerate ...

In today’s Pharma Pulse, HHS Secretary RFK Jr. centralizes department operations under CMS leadership, while a new telehealth model shows a 66% reduction in repeat ER visits for older adults.

Turning to market access, Eli Lilly has entered a $100 million licensing agreement with CSL Limited for clazakizumab. While CSL maintains the rights for kidney-related cardiovascular trials, Lilly ...

In the first part of his Pharma Commerce video interview, John Stanford, Incubate’s executive director, explains how third round of CMS drug selections brings physician-administered medicines under ...

DHL Group—capitalizing off the momentum garnered from the LAX cold storage project —is expanding its dedicated airfreight cold chain network, aimed at strengthening global logistics for ...

A 2026 industry survey finds mounting pressure from PBMs, federal pricing reforms, and compliance scrutiny, as manufacturers ...

This eBook highlights Werner’s premium and expedited shipping solutions designed specifically to address the high-stakes requirements of the $1.6 trillion global pharmaceutical industry. It details ...

The online pharmacy is collaborating with a digital health provider to combine direct-to-patient GLP-1 dispensing with virtual clinical support, highlighting evolving supply chain and regulatory ...

The $300 Billion Pharma Patent Cliff: Why M&A Is Exploding ...

In the first part of his Pharma Commerce video interview, Dan Chancellor, Norstella’s vice president of thought leadership, explains that despite a looming loss of exclusivity affecting up to $300 ...